Subcutaneous Administration of Bortezomib: Strategies to Reduce Injection Site Reactions
نویسندگان
چکیده
منابع مشابه
Subcutaneous Administration of Bortezomib: Strategies to Reduce Injection Site Reactions
Bortezomib (Velcade) is approved by the FDA for IV or SC injection in select patients with multiple myeloma or mantle cell lymphoma. The SC route functions as an alternative to IV administration for patients with poor IV access. Learn about effective strategies used to reduce injection site reactions that can occur with SC delivery.
متن کاملTolerability of Velcade (Bortezomib) subcutaneous administration using a maximum volume of 3 mL per injection site.
Subcutaneous injection is now commonly used as a standard for bortezomib administration. The bortezomib (Velcade(®)) product monograph recommends that intravenous injections be prepared at a concentration of 1 mg/mL, while subcutaneous injections may be prepared at a concentration of 2.5 mg/mL. Many institutions and subcutaneous administration guidelines use 2 mL as the maximum volume for subcu...
متن کاملSelf-administration of mercury by subcutaneous injection.
An unmarried woman of 21 developed diabetes mellitus in 1957 when aged 12. Her subsequent management was often complicated by diabetic ketoacidosis and coma, eventually traced to failure to administer her insulin correctly. At a number of centres in the London area she received psychiatric treatment, with a diagnosis of inadequate immature personality and psychopathic features. In 1962, at the ...
متن کاملSubcutaneous Administration of Bortezomib: A Pilot Survey of Oncology Nurses
Subcutaneous (SC) administration of the proteasome inhibitor bortezomib was approved in the United States and European Union in 2012. There is limited guidance regarding how to administer SC bortezomib and a general lack of clear direction on optimal techniques for administering SC chemotherapy injections. Nurses may be utilizing different techniques, and inconsistent techniques may result in i...
متن کاملAluminium and injection site reactions.
AIMS To alert pathologists to the spectrum of histological appearances that may be seen in injection site reactions related to aluminium. METHODS Four cases of injection site reaction were examined microscopically using routine staining with haematoxylin and eosin, electron microscopy and by electron probe microanalysis. RESULTS As in previous reports, all four cases included collections of...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the Advanced Practitioner in Oncology
سال: 2012
ISSN: 2150-0878
DOI: 10.6004/jadpro.2012.3.6.8